ReviewSenataxin: Genome Guardian at the Interface of Transcription and Neurodegeneration
Keywords: AD; Alzheimer's disease; SOD1; superoxide dismutase 1; ALS; amyotrophic lateral sclerosis; ALS-FTD; ALS with frontotemporal lobar degeneration; FRDA; Friedreich ataxia; FXS; fragile X syndrome; SETX; senataxin; AOA2; ataxia with oculomotor apraxia type 2;